Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Health and Social Care Secretary Sets Out Plan for Patients With New Funding to Bolster Social Care Over Winter
‘Our plan for patients’ will inject £500 million of additional funding into adult social care […]
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics
Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat […]
Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer
Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated […]
Pattern Health Closes $3.3M Series A to Expand Digital Health Research and Clinical Implementation Capabilities
Pattern Health, a digital health company, today announced the closing of a $3.3 million series A funding […]
Fujitsu, Tohoku University Embark on Strategic Alliance to Realize 'well-being Society'
Fujitsu Limited and Tohoku University today announced the start of a strategic alliance to accelerate […]
Concord Health Partners Adds Healthcare Private Equity Veteran Robert Schulz as Managing Director
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the […]
Wheeler Bio Announces Roger Lias, Ph.D. as President and Chief Operating Officer
Wheeler Bio, a new contract development and manufacturing organization (CDMO) specializing in the cell line […]
Gilead Sciences Completes Acquisition of MiroBio
GMiroBioilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to […]
Cumulus Neuroscience Appoints Digital Health and Pharmaceutical Executive Aman Bhatti, MD as Chief Executive Officer
Cumulus Neuroscience (Cumulus; the Company), a global digital health company developing multi-domain digital biomarkers for the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more